Improving de novo sequencing methods and post translational modification screening tools for the analysis of complex protein mass spectra

Significance of the Topic

The precise sequencing of intact proteins and the accurate detection of post-translational modifications (PTMs) are essential for understanding protein function, dynamics and regulatory mechanisms. Top-down mass spectrometry (TDMS) empowered by radical-driven dissociation methods delivers detailed sequence and modification information but generates highly complex spectra that demand advanced computational tools for confident interpretation.

Objectives and Study Overview

This study presents two major advancements within the OmniScape software: an improved de novo sequencing algorithm and an ultra-fast PTM screening workflow. The goal is to accelerate sequence tag generation, enhance identification confidence and enable real-time screening of billions of proteoforms.

Methodology and Instrumentation

The new features are implemented in C++ and integrated into OmniScape. Key methodological elements include:

• Deisotoping with the OmniWave algorithm to extract monoisotopic peaks.
• Graph-based de novo sequencing: constructs a network of isotopic distributions linked by neutral losses, hydrogen shifts and fragment-type mass gaps.
• PTM screening: brute-force enumeration for small search spaces and heuristic pruning for very large proteoform sets (2^n configurations), enabling convergence in seconds.
• Homology search via MS-BLAST for sequence tag matching and a dedicated confirmation workflow.

Instrumentation used for evaluation:

• Bruker ScimaX MRMS (ECD fragmentation) for AMPK-β analysis.
• Bruker maXis II ETD for carbonic anhydrase II (CA II) spectra.

Main Results and Discussion

The enhanced PTM screening workflow processed over 34 billion proteoform candidates in seconds, pinpointing the most probable modified sequence map. The updated de novo algorithm achieved:

• Longer and more accurate sequence tags, improving MS-BLAST identification scores.
• Over 10-fold speed improvements compared to the previous version.
• Accurate fragment-ion-type assignment (a, c, z, y) enabling directional tag determination.

For CA II, the improved system yielded higher confidence identifications and revealed additional a-type fragments that defined N-terminal trajectories. Subgraphs of isotopic distributions illustrated the scoring benefits of correlating multiple relationships across charge states.

Benefits and Practical Applications

The new workflows offer:

• Rapid screening of extremely large PTM variant spaces, critical for complex proteomics and QA/QC pipelines.
• Enhanced confidence in de novo tag generation, supporting discovery of unknown or modified proteins.
• Integration into high-throughput top-down MS environments for pharmaceutical, clinical and structural biology research.

Future Trends and Perspectives

Potential directions include:

• Integration of machine-learning models to further refine scoring and handle novel PTM chemistries.
• Real-time spectral interpretation for online monitoring and adaptive acquisition strategies.
• Expansion to even larger proteomes and complex biological matrices.
• Enhanced support for multi-omic data integration and structural proteomics applications.

Conclusion

The updated OmniScape platform delivers a breakthrough in top-down proteomics by combining an ultrafast PTM screening workflow with a highly accurate de novo sequencing algorithm. These advancements significantly boost throughput, identification confidence and practical utility for complex protein analysis.

References

No formal literature list provided in the source document.